AGENUS INC Long-term Debt and Lease Obligation
AGENUS INC (AGEN) had Long-term Debt and Lease Obligation of $142.38 million as of 2017-12-31, per its 10-K filed 2019-03-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2019-03-18
- 2017-12-31: Long-term Debt and Lease Obligation $142.38M.
- 2017-09-30: Long-term Debt and Lease Obligation $123.29M.
- 2017-06-30: Long-term Debt and Lease Obligation $138.53M.
- 2017-03-31: Long-term Debt and Lease Obligation $134.16M.
| Period end | Long-term Debt and Lease Obligation | Long-term Debt and Lease Obligation as first filed |
|---|---|---|
| 2017-12-31 | $142.38M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $123.29M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $138.53M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $134.16M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $130.54M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $126.26M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $122.13M 10-Q · filed 2016-08-04 | |
| 2015-12-31 | $114.33M 10-K · filed 2017-03-16 | $114.33M 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |